| Name | Description |
| Australia | Committed to the development and production of high quality aquatic vaccines for cold and warm water species in Australia. |
| Chile | Committed to the development of new vaccines for control of the main diseases affecting cultured salmonid species in Chile. |
| United States | In the year 1999 a decision was made to enter the Aquatic Animal Health market in the USA following the lead of Intervet International. The first product licensed was CHORULON® (hCG). The second product licensed was a live attenuated vaccine for the prevention of Enteric Septicemia of Catfish (ESC) caused by Edwardsiella ictaluri. |
